Glycemic Effects of Nebivolol Compared With Metoprolol Extended Release and Compared With Hydrochlorothiazide In Hypertensive Patients With Type 2 Diabetes Mellitus: A Pilot Study.

Trial Profile

Glycemic Effects of Nebivolol Compared With Metoprolol Extended Release and Compared With Hydrochlorothiazide In Hypertensive Patients With Type 2 Diabetes Mellitus: A Pilot Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2011

At a glance

  • Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Metoprolol
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 28 Jul 2011 Additional location (Puerto Rico) added as reported by ClinicalTrials.gov.
    • 22 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top